BR9913618A - Genes essenciais de c. albicans e um método para peneirar substâncias antimicóticas usando ditos genes - Google Patents

Genes essenciais de c. albicans e um método para peneirar substâncias antimicóticas usando ditos genes

Info

Publication number
BR9913618A
BR9913618A BR9913618-0A BR9913618A BR9913618A BR 9913618 A BR9913618 A BR 9913618A BR 9913618 A BR9913618 A BR 9913618A BR 9913618 A BR9913618 A BR 9913618A
Authority
BR
Brazil
Prior art keywords
genes
albicans
sifting
essential
antimycotic substances
Prior art date
Application number
BR9913618-0A
Other languages
English (en)
Inventor
Jean-Louis Lalanne
Corinne Rocher
Nicolas Chalwatzis
Thomas Leeuw
Daniel Margerie
Almut Nitsche
Jutta Reinhard-Rupp
Original Assignee
Aventis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma filed Critical Aventis Pharma
Publication of BR9913618A publication Critical patent/BR9913618A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: <B>"GENES ESSENCIAIS DE C. ALBICANS E UM MéTODO PARA PENEIRAR SUBSTâNCIAS ANTIMICóTICAS USANDO DITOS GENES"<D>. A presente invenção refere-se a genes essenciais de C. albicans e seu uso em um método para o peneiramento de substâncias antimicóticas.
BR9913618-0A 1998-09-11 1999-09-13 Genes essenciais de c. albicans e um método para peneirar substâncias antimicóticas usando ditos genes BR9913618A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98402255A EP0999284A1 (en) 1998-09-11 1998-09-11 Method for screening antimycotic substances using essential genes from c.albicans, and said genes
PCT/EP1999/007376 WO2000015838A2 (en) 1998-09-11 1999-09-13 Essential genes from c. albicans and a method for screening antimycotic substances using said genes

Publications (1)

Publication Number Publication Date
BR9913618A true BR9913618A (pt) 2001-05-22

Family

ID=8235486

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913618-0A BR9913618A (pt) 1998-09-11 1999-09-13 Genes essenciais de c. albicans e um método para peneirar substâncias antimicóticas usando ditos genes

Country Status (21)

Country Link
EP (2) EP0999284A1 (pt)
JP (1) JP2002525073A (pt)
KR (1) KR20010080880A (pt)
CN (1) CN1331753A (pt)
AU (1) AU776818B2 (pt)
BR (1) BR9913618A (pt)
CA (1) CA2341315A1 (pt)
CZ (1) CZ2001877A3 (pt)
EA (1) EA200100336A1 (pt)
HR (1) HRP20010179A2 (pt)
HU (1) HUP0103974A2 (pt)
ID (1) ID28903A (pt)
IL (1) IL141748A0 (pt)
NO (1) NO20011218L (pt)
NZ (3) NZ526695A (pt)
PL (1) PL348025A1 (pt)
SK (1) SK2992001A3 (pt)
TR (3) TR200200207T2 (pt)
WO (1) WO2000015838A2 (pt)
YU (1) YU22001A (pt)
ZA (1) ZA200101500B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
EP1281769A1 (en) * 2001-08-01 2003-02-05 Aventis Pharma S.A. Screening-method for inhibitors of folate-synthesis-pathway enzymes
GB0820631D0 (en) * 2008-11-11 2008-12-17 London School Hygiene & Tropical Medicine Vectors
CN109810991B (zh) * 2019-03-02 2021-11-12 昆明理工大学 二氢蝶酸合酶基因folP的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976848A (en) * 1990-08-03 1999-11-02 Dow Agrosciences Llc Method of identifying potential fungicides using dihydroorotate dehydrogenase inhibition assay
DE69434662T2 (de) * 1993-05-24 2006-12-07 Takara Bio Inc., Otsu Kodierung eines Gens für ein die Aureobasidinempfindlichkeit regulierendes Protein
ES2139034T3 (es) * 1993-05-25 2000-02-01 American Cyanamid Co Seleccion de citocrome p-450 reductasa con respecto a inhibidores de la biosintesis del ergosterol.
US5418144A (en) * 1993-05-25 1995-05-23 American Cyanamid Company Spindle pole body screen for fungicides
WO1995011969A1 (en) * 1993-10-25 1995-05-04 Ribogene, Inc. Methods for screening for antimycotics
US5602097A (en) * 1994-09-13 1997-02-11 Ceres Technologies, Inc. Synthetic antibiotics
CA2250129A1 (en) * 1996-04-01 1997-10-09 Scriptgen Pharmaceuticals, Inc. Candida albicans tata-binding protein, nucleic acid and assays
AU3507397A (en) * 1996-06-26 1998-01-14 University Of Massachusetts Novel tata-box binding protein-associated factors essential for yeast viability
EP0816511B2 (en) * 1996-06-27 2006-06-14 Clondiag Chip Technologies GmbH Method of screening substances
GB9704162D0 (en) * 1997-02-28 1997-04-16 Medical Res Council Assay methods and means
US5908748A (en) * 1997-03-06 1999-06-01 Children's Hospital Medical Center Species-specific yeast TFIIB sequence
DE19713572A1 (de) * 1997-04-02 1998-10-22 Hoechst Ag Verfahren zum Screening von antimykotisch wirkenden Substanzen

Also Published As

Publication number Publication date
CA2341315A1 (en) 2000-03-23
IL141748A0 (en) 2002-03-10
TR200200208T2 (tr) 2002-04-22
YU22001A (sh) 2005-06-10
EA200100336A1 (ru) 2001-10-22
KR20010080880A (ko) 2001-08-25
NO20011218D0 (no) 2001-03-09
NZ526695A (en) 2004-10-29
WO2000015838A2 (en) 2000-03-23
ZA200101500B (en) 2001-08-28
WO2000015838A3 (en) 2001-02-01
HUP0103974A2 (hu) 2002-03-28
AU776818B2 (en) 2004-09-23
HRP20010179A2 (en) 2002-04-30
TR200100697T2 (tr) 2001-06-21
EP1112382A2 (en) 2001-07-04
SK2992001A3 (en) 2001-12-03
CZ2001877A3 (cs) 2001-10-17
JP2002525073A (ja) 2002-08-13
TR200200207T2 (tr) 2002-06-21
EP0999284A1 (en) 2000-05-10
NZ526696A (en) 2004-10-29
AU6089499A (en) 2000-04-03
ID28903A (id) 2001-07-12
CN1331753A (zh) 2002-01-16
NZ510237A (en) 2003-12-19
NO20011218L (no) 2001-04-25
PL348025A1 (en) 2002-05-06

Similar Documents

Publication Publication Date Title
ATE236146T1 (de) Alpha-9 integrin antagonisten sowie diese enthaltende anti-inflammatorisch wirkende zusammensetzungen
DE602004007257D1 (de) Hydroxy-diaryl-carbaldehyd- oxim-verbindungen und deren verwendung als oestrogenwirksame substanzen
ATE260033T1 (de) Biozide zusammensetzung und deren verwendung
ATE271066T1 (de) Lösliche mutante ctla4 moleküle und deren verwendung
BR9600148A (pt) Quinazolinonas 2,8-dissubstituídas processo para sua preparação medicamentos e uso
DE69938880D1 (de) Zementzusatz und seine Verwendung in Zementzusammensetzungen
DE60140377D1 (de) Mch antagonisten und deren verwendung zur behandlung von fettleibigkeit
DE59601122D1 (de) N-(Benzofurazanyl)-Arylsulfonamide und ihre Analoge verwendbar als Endothelin-Rezeptor-Antagonisten
DE69941743D1 (de) Teiaufteilung von Bildern im komprimierten Bereich
BRPI0107815B8 (pt) compostos derivados aminados de di-hidro-1,3,5- triazina, processo de preparo destes, composição farmacêutica e uso dos mesmos
DE69842237D1 (de) Azeotropische Zusammensetzungen enthaltend 1,1,1,2,3,3,3-Heptafluorpropan und Verfahren, die diese Zusammensetzungen verwenden
DE69806891D1 (de) Grobkörniger kaolinton und herstellungsverfahren
ID29551A (id) Perbaikan-perbaikan dalam dokumen-dokumen berharga/penting dan substrasi-substrasinya
ATE218534T1 (de) Substituierte aminoverbindungen und ihre verwendung als analgetisch wirksame substanzen
ATA187694A (de) Vorrichtung, insbesondere distanzanker für justierung und befestigung von rahmen
IL156262A0 (en) Anti-cd28 antibodies having no mitogenic activity and pharmaceutical compositions containing the same
BR9913618A (pt) Genes essenciais de c. albicans e um método para peneirar substâncias antimicóticas usando ditos genes
PT1000063E (pt) Derivados de 4-oxo-3,5-di-hidro-4h-piridazino¬4,5-b|indole-1-acetamida processo para sua preparacao e sua aplicacao em terapeutica
WO2001070776A3 (en) Nimr compositions and their methods of use
ATE251902T1 (de) Pharmazeutische zusammensetzung zur reduzierung der mcp-1 proteinsynthese
AU7402601A (en) Protein complexes and assays for screening anti-cancer agents
DE60013191D1 (de) Tensidzusammensetzung und deren Verwendung
IT1297022B1 (it) Complesso di ferro-succinilcaseina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono
DE60029895D1 (de) Material zur Aufnahme von Urin und anderen Ausflüssen von Tieren
DE59901532D1 (de) Pigmentzubereitungen in Granulatform

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.